1. Home
  2. NAMS vs ENVA Comparison

NAMS vs ENVA Comparison

Compare NAMS & ENVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$31.61

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Logo Enova International Inc.

ENVA

Enova International Inc.

HOLD

Current Price

$232.71

Market Cap

4.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAMS
ENVA
Founded
2019
2011
Country
Netherlands
United States
Employees
100
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.1B
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
NAMS
ENVA
Price
$31.61
$232.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
7
Target Price
$46.75
$185.71
AVG Volume (30 Days)
977.5K
432.3K
Earning Date
05-06-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
55.05
EPS
N/A
3.46
Revenue
N/A
$3,151,653,000.00
Revenue This Year
$17.96
$149.64
Revenue Next Year
$540.65
$16.42
P/E Ratio
N/A
$67.97
Revenue Growth
N/A
18.58
52 Week Low
$21.14
$99.61
52 Week High
$42.21
$246.38

Technical Indicators

Market Signals
Indicator
NAMS
ENVA
Relative Strength Index (RSI) 42.75 62.92
Support Level $29.23 $220.13
Resistance Level $31.72 $246.38
Average True Range (ATR) 1.86 9.24
MACD -0.38 -2.07
Stochastic Oscillator 13.64 47.92

Price Performance

Historical Comparison
NAMS
ENVA

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

Share on Social Networks: